October 2022 Newsletter

Published on 11/01/2022

11 min read

Replay the Live Event

Thanks to all the in-person and virtual attendees of our first-ever Investor Day! You can catch a replay of the live web-stream at the link below.

New Collaboration

As announced at our Investor Day, we’ll be collaborating with Memorial Sloan Kettering Cancer Center to further cancer research through Data Driven Medicine.

New Partnership

We’re thrilled to share a partnership united in purpose: We’ve partnered with Boundless Bio to accelerate cancer drug clinical trial development.

White Paper for RNAtarget Solution

Read our SOPHiA DDM™️ Dx ROS performance evaluation study and make confident data-driven decisions that improve patient care.

How the Future of Genomic Analysis is Already Furthering Breast Cancer Research

The advancement of genomic analysis technology revolutionizes breast cancer research, as it provides better breast tumor classifications, which then leads to enhanced clinical management or precision oncology.

pink dots icon

Upcoming Events

In-person
December 10, 2022
Location: North America
pink dots icon

In The News

CFO Thought Leader

Realizing the Potential of Data at Scale

Nasdaq Trade Talks

Why Data-Driven Medicine is the Future of Healthcare

The Pathologist

Cloud-based Cancer Care

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.
';